Enseval Putera Megatrading Tbk PT
IDX:EPMT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/IC
Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.
Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.
Valuation Scenarios
If EV/IC returns to its 3-Year Average (0.8), the stock would be worth Rp2 579.65 (9% upside from current price).
| Scenario | EV/IC Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0.7 | Rp2 360 |
0%
|
| 3-Year Average | 0.8 | Rp2 579.65 |
+9%
|
| 5-Year Average | 0.8 | Rp2 604.48 |
+10%
|
| Industry Average | 2.7 | Rp8 654.72 |
+267%
|
| Country Average | 0.7 | Rp2 245.18 |
-5%
|
Forward EV/IC
Today’s price vs future invested capital
Peer Comparison
| Market Cap | EV/IC | P/E | ||||
|---|---|---|---|---|---|---|
| ID |
|
Enseval Putera Megatrading Tbk PT
IDX:EPMT
|
6.4T IDR | 0.7 | 8.1 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
100.3B USD | 5 | 23.1 | |
| US |
|
Cencora Inc
NYSE:COR
|
59.9B USD | 3.2 | 36.9 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
59.5B USD | 3.2 | 36.6 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
45.5B USD | 3.1 | 27.4 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
32.1B AUD | 4.8 | 35.3 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.4B CNY | 0.6 | 11.1 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.6B USD | 1.2 | 21.7 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
58.5B CNY | 2.1 | 20.6 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 4.7 | 89.6 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
57.6B HKD | 0 | 7.2 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0.3 |
| Median | 0.7 |
| 70th Percentile | 1.4 |
| Max | 115 637.5 |
Other Multiples
Enseval Putera Megatrading Tbk PT
Glance View
PT Enseval Putera Megatrading Tbk engages in the distribution and supply of pharmaceutical, consumer, medical equipment, cosmetics and other trading products. The company is headquartered in Jakarta, Dki Jakarta and currently employs 5,000 full-time employees. The firm is engaged in trading and distribution of consumer products and medical devices. The firm focuses its activities on distribution and trading services through four divisions: pharmaceutical products, consumer products, medical devices and chemical products. The company provides services across digital platform, distribution and sales, health care, marketing and logistics. The company offers a range of products, such as consumer product, prescription and non-prescription medicines, raw materials, medical devices, clinics and veterinary products. Its subsidiaries include PT Tri Sapta Jaya, which distributes pharmaceutical and medical equipment; PT Millenia Dharma Insani, which operates clinics under the brand name of Mitrasana; PT Enseval Medika Prima, which focuses on trading of medical devices, and PT Renalmed Tiara Utama, which supplies materials and hemodialysis machines.
